About this trial
The Gene Discovery Core at The Manton Center for Orphan Disease Research based at Boston Children's Hospital studies families with rare, poorly understood or undiagnosed, but suspected genetic conditions. The primary goal of the research is to better understand the genes and proteins (gene products) involved in rare diseases. The researchers hope that our studies will allow for improved diagnosis and treatment of individuals with rare disease in the future. Individuals with any rare/undiagnosed condition are eligible to enroll.
Enrollment includes:
* Providing DNA and tissue samples (when available) * Access to participants' medical records * Access to genomic data (when available)
Samples are used for genetic analysis (primarily exome and genome sequencing or reanalysis) to identify the genetic cause for the individual's illness. Individual research results are returned to families through their health care provider after confirmation in a clinical lab. If a cause is identified, that can be reported back to the family through their health care provider and the study's genetic counselor. When possible, the investigators also collect samples from parents and full-siblings as well as any other affected family members.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Having a known or uncertain rare diagnosis which may have a poorly understood genetic component and/or be a relative to a person with such a diagnosis
Disqualifiers
Not having such a diagnosis and/or not being related to such an individual
Trial population
Individuals with a rare or unknown but presumed genetic diagnosis and their family members.
Trial design
Family-based
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Identification of rare or novel disease-causing genetic variants for a participant's disorder
Functional analysis, including animal modeling and cell line assays, will be performed for novel candidate genes. When a molecular diagnosis is identified for a family, this is reported back through a designated health care provider.
Characterization of clinical features of novel and rare disorders using Human Phenotype Ontology (HPO) terms
As known and new disease genes are identified the resulting genotypes are correlated with subject phenotypes.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.